| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.967 | 7 | 0 | 1990 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.911 | 4 | 0 | 1986 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.959 | 4 | 0 | 1996 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.944 | 4 | 0 | 1991 | 2020 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
group | 0.360 | None | 1.000 | 2 | 0 | 1998 | 2007 | ||||||||
|
selenoprotein P | 0.545 | 0.769 | 8.3E-07 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2000 | 2008 | ||||||||
|
transient receptor potential cation channel subfamily M member 7 | 0.531 | 0.731 | 5.2E-16 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
thioredoxin reductase 1 | 0.529 | 0.692 | 1.6E-06 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 2002 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.913 | 9 | 0 | 1994 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.100 | None | 0.846 | 6 | 0 | 1999 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 1995 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.833 | 2 | 0 | 2001 | 2017 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1996 | 2017 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.981 | 2 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 7 | 0.446 | 0.885 | 1.0E-09 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2015 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2018 | ||||||||
|
secreted frizzled related protein 2 | 0.544 | 0.731 | 1.7E-03 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
POU class 1 homeobox 1 | 0.548 | 0.654 | 4.5E-02 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.900 | 1 | 0 | 1994 | 2012 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1995 | 2018 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.090 | None | 1.000 | 3 | 0 | 2002 | 2014 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
group | 0.090 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.090 | None | 0.778 | 1 | 0 | 1996 | 2013 | ||||||||
|
paired box 8 | 0.477 | 0.731 | 1.00 |
|
group | 0.080 | None | 1.000 | 3 | 0 | 1999 | 2011 |